Data, analysis and expert opinions are available in our Insights:
Most content available in French only.
Since April, new rules regarding access to French medico-administrative healthcare data (SNIIRAM, EGB, PMSI) have had a deep impact on healthcare data challenges.
With the creation of the SNDS (Système National des Données de Santé) and the INDS (Institut National des Données de Santé), plus new regulations regarding access to these datasets, it has become compulsory for all stakeholders to fully integrate these evolutions into their strategy.
To help accompany you on these key strategic issues, our expert teams are there to help you to:
For more information, please contact us.
Your bi-monthly newsletter about the pharmaceutical market in France and abroad.